https://www.avient.com/products/fiber-line-engineered-fiber-solutions/high-performance-synthetic-fibers/carbon-fiber
X - Ray Permeable
https://www.avient.com/products/engineered-polymer-formulations/sustainable-formulations/gravi-tech-lead-replacement-formulations
Several grades of Gravi-Tech materials used for X-ray devices provide radiation shielding performance comparable to that of lead, yet these grades are 37 percent lighter.
https://www.avient.com/knowledge-base/article/overmolding-part-design
Spiral flow test performed using 0.0625" x 0.375" channel at 400°F
https://www.avient.com/sites/default/files/2020-10/luxury-closures-gravi-tech-design-guide-2.0-application-specific.pdf
CHAPTER 1 | APPLICATION SUMMARY
Design Guide 5
GT5200-0013
GT6000-0004
GT7300-0006
GT5200-5003
GT6000-5002
GT7300-5007
Specific
Gravity* 2.0 3.0 2.0 2.5 2.6 2.2
Color
Options* Various Various Black to Grey Black Various Various
Electroplating No Possibly Yes Possibly Possibly Yes
Base
Resin PP PA6 ABS PP PA6 ABS
FDA
Compliant* Yes Yes Yes Yes No Yes
Region
Produced
North
America
North
America
North
America Europe Europe Europe
Full
Name
X GT5200-0013
PT White
X GT6000-0004
PT White
X GT7300-0006
PT Black
GT7300-5003
Black FD
GT6000-5002
EI White 1
GT7300-5007
X2 White FD
*Please contact Avient for additional information
6 Gravi-Tech
CHAPTER 2 | PROCESS SETTINGS
Density Modified Formulations
Gravi-Tech™ polymer-metal composites are high-density materials developed as thermoplastic-
based alternatives to metals.
This will
result in stronger parts due to the locked in
FIGURE 43 - Non-Newtonian Fluid Flow
Low Level of Orientation Frozen Layer
Highly Oriented Laminates Gate
Transducer A
Transducer B
Hydraulic x 10
Filling Hold Start of
mold shrinkage
Time
Pack
P
ss
A
B
FIGURE 45 - Non-Newtonian fluid flow
Relative Viscosity = Transfer Position * Fill Time
Shear Rate = 1
Fill time
FIGURE 46 - Pressure vs.
The modulus of steel is
3 x 107 psi
https://www.avient.com/sites/default/files/resources/AVNT Fermium Conference - May 2023 w NonGAAP Recs.pdf
& Canada
40%
38%
17%
Q1 2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
18%
23%
Building and
6%Telecommunications
END MARKET REVENUE
(1) Total company sales and adjusted EBITDA of $846M and $134M, respectively, include intercompany sales eliminations and corporate costs
$537M $91M
$310M $64M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$134M$846M
(1)
13
Q1 2023 SALES BY REGION
Yo Y C H A N G E ( E X C L .
F X )
-10%
-11%
-3%
-12%
14
Avient ex.
https://www.avient.com/sites/default/files/resources/Innovation%2520Day%2520-%2520May%25202014.pdf
CT scanners)
Creates value by eliminating the
need for machining and secondary
operations, removing weight,
streamlining production and
improving cost efficiencies
PolyOne Corporation Page 52
Medical Device Solutions
Catheters made using NEU™ View
patent-pending technology are
optically translucent, and have
superior contrast under X-ray
(radiopaque) when compared with
alternative catheter materials
Formulations for cardiovascular and
intravascular catheters are
application-specific, incorporating
medical-grade polymers, additives,
color, and healthcare-centric
manufacturing practices
Only commercially available product
that has excellent visibility, both
optically and under X-ray, to bolster
clinician confidence and offer
significant market advantage
PolyOne Corporation Page 53
Consumer Electronics Solutions
Ability to offer multiple technology
solutions on a global basis for this
industry, where many OEMs design in
one region, prototype in another, and
manufacture in yet another
Sustainable / “green” solutions help
customers to differentiate in this
market
New formulations for emerging
wearables market that meet skin
contact requirements and aesthetic
needs
PolyOne Corporation Page 54
Building &
17%
Electrical &
8%
19%
At a Glance
Global Specialty Engineered Materials
2013 Revenues: $0.6 Billion Solutions
2013 Revenue by Industry Segment Expanding Profits
1.1% 1.3%
3.4%
5.1%
9.6%
8.0%
8.6%
9.3%
12-16%
2006 2007 2008 2009 2010 2011 2012 2013 Q1
2014
2015
Operating Income % of Sales
Target
43%
33%
11.6%
PolyOne Corporation Page 55
Building &
Electrical &
Target
At a Glance
Global Color, Additives and Inks
2013 Revenues: $0.9 Billion Solutions
Expanding Profits
1.7%
4.6% 5.1% 5.5%
7.2% 8.1%
9.7%
12.2%
12-16%
2006 2007 2008 2009 2010 2011 2012 2013 Q1
2014
2015
Operating Income % of Sales
44%
37%
2013 Revenue by Industry Segment
13.8%
PolyOne Corporation Page 56
At a Glance
Designed Structures and Solutions
Solutions 2013 Revenues: $0.6 Billion
Expanding Profits
2.2%
8 - 10%
6.5%
2012 PF Q1 2013 Q1 2014 2015
Operating Income % of Sales
0.2%
Target
96%
1%
Building &
32%
26%
2013 Revenue by Industry Segment
PolyOne Corporation Page 57
5.5%
6.9%
3.8% 3.6%
5.5%
4.3%
6.3%
7.2%
2006 2007 2008 2009 2010 2011 2012 2013 Q1
2014
Operating Income % of Sales
At a Glance
Performance Products and Solutions
Solutions
Expanding Profits
2013 Revenues: $0.8 Billion
81%
1%
9-12%
Target
2013 Revenue by Industry Segment
8%
Building &
4% Electrical &
1%Industrial
2015
7.7%
PolyOne Corporation Page 58
2.6%
3.0%
3.5%
4.0%
4.6%
5.6%
6.4%
5.9%
6 - 7.5%
2006 2007 2008 2009 2010 2011 2012 2013 Q1
2014
2015
Operating Income % of Sales
15.3%
46.0%
2006 Q1 2014
At a Glance
Distribution
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and
equity over a 5 quarter period
Solutions 2013 Revenues: $1.1 Billion
ROIC* Expanding Profits
Target
Building &
Electrical &
24%
23%
6.1%
http://www.polyone.com/Pages/VariationRoot.aspx
https://www.avient.com/sites/default/files/2022-04/Asia SEM Healthcare Product Selection Guide_CN.pdf
在对普通消毒剂的耐受性方面优于PC/ABS、
PC/PET和COPE
暴露在普通医院消毒剂下72小时后仍能保持
抗拉强度,相较于PC混合物和COPE,具有
更出色的长期耐化学性
具有良好的抗冲击性和耐热性
有自然色等级、标准医用颜色或定制预着色
产品可供选择
医疗设备外壳
核磁共振成像、X射线、CT扫描仪部件
手术器械,如吻合器、解剖器、剪刀等
自动注射笔
测试项 比重
熔体流动指数
(230OC,
2.16KG)
抗拉强度 挠曲强度 挠曲模量 冲击强度
缺口,IZOD 测试项
方法 ASTM D-792 ASTM D-1238 ASTM D-638 ASTM D-790 ASTM D-790 ASTM D-256 ASTM D-257
单位 -- g/10min MPa MPa MPa J/m Ohms/sq.
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
17
Capex / Revenue
2021E (%)
AVIENT IS ASSET LIGHT
Avient Specialty
Other
2
3 2 2 3 3 3
3 4 5 5 5 5 5 6 6 7
7
9
t
(E
x
c
l.
https://www.avient.com/sites/default/files/2022-08/AVNT Aug 2022 Presentation - Jefferies.pdf
WHAT WE DO: MATERIAL SCIENCE
5
CUSTOM
FORMULATION
SUSTAINABILITY FOR A BETTER TOMORROW
Revenue From Sustainable Solutions* 2016-2021
$310
205
140
80
75
45
40
20
$915M2021 Sales
*Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”)
**2020 is Pro Forma to include full year of the Clariant Color business
Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12%
6
S E CO N D Q UART E R 2022
RE S U LT S
$122
$134
$0.87
$0.98
Q2 2022 PERFORMANCE
(TOTAL COMPANY)
8
Sales Adjusted Operating Income
$1,235
$1,302
+ 5%
Adjusted EPS
+ 10% + 13%
(in millions) (in millions)
(+ 10% excluding FX) (+ 16% excluding FX) (+ 20% excluding FX)
Q2 2022 SEGMENT PERFORMANCE
9
CAI
$624
$649
SEM Distribution
$86
$94
+ 4% + 9%
$404
$443
$24
$27
+ 10% + 13%
$241 $244
$37 $37
+ 1% Flat
(+ 10% excluding FX) (+ 16% excluding FX) (+ 6% excluding FX) (+ 3% excluding FX)
Q2 2021 $1,235 $122
Sustainable Solutions 17 7% 7
Healthcare 23 14% 5
Composites (ex Outdoor High Performance) 10 20% 4
Growth in Asia / LATAM 5 3% 1
Other 69 11% 5
Sub-total $1,359 10% $144
Outdoor High Performance Impact (9) (5)
Wage Inflation and Overtime (7)
Other Supply Chain Costs (2)
Clariant Color Integration Synergies 7
Incentives, Other Employee Costs 4
FX (48) (7)
Q2 2022 $1,302 5% $134
Q2 2022 SALES AND OPERATING INCOME
(TOTAL COMPANY)
10
Sales Growth Rate
Operating
Income$ millions
EBITDA
Q2 EBITDA BRIDGE
11
Price increases more than
offsets raw material and
supply chain impacts
Q2 2021 $ 159
Demand (29)
$ millions
CAI:
Price / Mix 87
Inflation (58)
SEM:
Price / Mix 36
Inflation (24)
Distribution:
Price / Mix 45
Inflation (41)
Net Price Benefit 45
Wage Inflation and Overtime (7)
Other Supply Chain Costs (2)
Clariant Color Integration Synergies 7
Incentives, Other Employee Costs 4
FX (7)
Q2 2022 $ 170
China Lockdowns / Russia Impact $ (14)
Outdoor High Performance (5)
Transportation (5)
12
Q2 '21 Adjusted EPS 0.87$
Color, Additives and Inks 0.11
Specialty Engineered Materials 0.01
Distribution 0.03
Corporate Costs 0.01
F/X (0.05)
Segment OI 0.11$
Interest Expense 0.03
Tax Rate (0.03)
Q2 '22 Adjusted EPS 0.98$
Q2 EPS BRIDGE
Key Updates
• Provided progress on 2030 Sustainability Goals
• Emphasized commitment to U.N.
https://www.avient.com/sites/default/files/2023-11/AVNT November IR Presentation.pdf
Avient 2011, 2018 and 2021 multiples reflect trailing 12 months EBITDA at December 31.
28
EV / 2023E EBITDA
6.5
8.5
11.0
8.9
12.0 11.9
10.9
9.9
8.2
16.3
13.8
11.9
9.6 9.5 9.5 9.2
7.7
11
21
O
ct
23
PM PP
FM
C C
Avient Historic Multiple
Avient Specialty
Other Specialty /
AP P E N DI X
30
Performance
Additives
16%
Pigments
12%
TiO2
Dyestuffs
2%
Polyethylene
Nylon
Polypropylene
Styrenic Block
Copolymer
Other Raw
Materials
33%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
2022 pro forma results for the acquisition of Avient Protective Materials
RAW MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
40%
37%
18%
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Building and
END MARKET REVENUE
$2,355M $402M
$1,300M $272M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$592M$3,653M
(1)
9%
32
(1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs
2022 REVENUE | $2 .4 BILLION
US & Canada
34%
38%
END MARKET REGION
33
34%
21%
Building &
1% Energy
2%
COLOR, ADDITIVES & INKS
2022 PRO FORMA REVENUE | $1 .3 BILLION
US & Canada
52%
35%
34
19%
8%Industrial
16%
9% Defense
Building &
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
32%
27%
14%
Building &
3%
1% Defense
1%
(18% of sales)
9%
2022 PROFORMA AVIENT REGIONAL SALES
27%
14%
17%
Building &
(37% of sales)Transportation
12%
Building &
US &
Canada
(40% of sales)
7%
56%
23%
7%
Building &
1%
LATAM
(5% of sales)
3%
35
BY END MARKET
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.